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From detection of individual metastases to
classification of lymph node status at the patient
level: the CAMELYON17 challenge
Pe´ter Ba´ndi, Oscar Geessink, Quirine Manson, Marcory van Dijk, Maschenka Balkenhol, Meyke Hermsen,
Babak Ehteshami Bejnordi, Byungjae Lee, Kyunghyun Paeng, Aoxiao Zhong, Quanzheng Li,
Farhad Ghazvinian Zanjani, Svitlana Zinger, Keisuke Fukuta, Daisuke Komura, Vlado Ovtcharov,
Shenghua Cheng, Shaoqun Zeng, Jeppe Thagaard, Anders B. Dahl, Huangjing Lin, Hao Chen, Ludwig Jacobsson,
Martin Hedlund, Melih C¸etin, Eren Halıcı, Hunter Jackson, Richard Chen, Fabian Both, Jo¨rg Franke,
Heidi Ku¨sters-Vandevelde, Willem Vreuls, Peter Bult, Bram van Ginneken, Jeroen van der Laak, and Geert Litjens
Abstract—Automated detection of cancer metastases in lymph
nodes has the potential to improve assessment of prognosis for
patients. To enable fair comparison between the algorithms for
this purpose, we set up the CAMELYON17 challenge in con-
junction with the IEEE International Symposium on Biomedical
Imaging 2017 conference in Melbourne.
Over 300 participants registered on the challenge website, of
which 23 teams submitted a total of 37 algorithms before the
initial deadline. Participants were provided with 899 whole-slide
images for developing their algorithms. The developed algorithms
were evaluated based on the test set encompassing 100 patients
and 500 whole-slide images. The evaluation metric used was a
quadratic weighted Cohen’s kappa.
We discuss the algorithmic details of the ten best pre-
conference and two post-conference submissions. All these par-
ticipants used convolutional neural networks in combination
with pre- and postprocessing steps. Algorithms differed mostly
in neural network architecture, training strategy and pre- and
postprocessing methodology.
Overall, the kappa metric ranged from 0.89 to -0.13 across
all submissions. The best results were obtained with pre-trained
architectures such as ResNet. Confusion matrix analysis revealed
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that all participants struggled with reliably identifying isolated
tumor cells, the smallest type of metastasis, with detection
rates below 40%. Qualitative inspection of the results of the
top participants showed categories of false positives, such as
nerves or contamination, which could be targets for further
optimization. Last, we show that simple combinations of the
top algorithms result in higher kappa metric values than any
algorithm individually, with 0.93 for the best combination.
Index Terms—breast cancer; sentinel lymph node; lymph node
metastases; whole-slide images; grand challenge
I. INTRODUCTION
BREAST cancer is the most common cancer amongwomen in the United States of America [1]. Within their
lifetime, 12% of women are diagnosed with breast cancer.
In 2017, an estimated 252,710 women were diagnosed with
breast cancer, which accounts for 30% of all diagnosed cancer
cases, and approximately 40,610 women died from the disease.
The prognosis of breast cancer patients is mainly determined
by whether the cancer is organ-confined or has spread to other
parts of the body [2]. An internationally accepted means to
classify the extent of cancer is the tumor, (regional) lymph
nodes, distant metastasis (TNM) staging system [3]. The TNM
staging system is one of the most important tools for clinicians
to select a suitable treatment for the patient. In breast cancer,
TNM staging takes into account the size of the tumor (T-stage),
whether the cancer has spread to the (regional) lymph nodes
(N-stage), and whether the tumor has metastasized to other
parts of the body (M-stage).
The axillary lymph nodes are typically the first location
breast cancer metastasizes to. Currently, the status of these
lymph nodes is almost always assessed by applying the
sentinel lymph node procedure. This procedure tries to identify
the nearest lymph nodes to which the tumor drains, which are
then excised for pathologic examination [4], [5]. Typically, a
blue dye and/or a radioactive tracer is injected in or near the
tumor prior to surgery to identify these sentinel lymph nodes.
After formalin fixation and paraffin embedding, a couple
of micrometers thin slices are cut from the excised nodes
and placed on glass slides (typically 3-5 sections per lymph
node). These slides are then stained with hematoxylin and
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eosin (H&E) to highlight the cell nuclei and the general
structural features of the tissue (Figure 1). Through micro-
scopic assessment the pathologist screens the slides for tumor
presence. If tumor cells are found, the pathologist measures
their extent in order to determine the pathologic N stage (pN-
stage) of the tumor. In case of unclear diagnosis on H&E,
immunohistochemical (IHC) staining for cytokeratin can be
used for clarification and is standard diagnostic practice in the
Netherlands [6], [7].
The histopathological analysis of lymph nodes is time con-
suming, tedious and pathologists may miss small metastases
[8]. The introduction of whole-slide imaging, which allows
for the high-resolution digitization of glass slides, has paved
the way for (partly) automating this work [9]. Automation can
potentially improve the efficiency and accuracy of histopatho-
logical lymph node assessment.
In the medical image analysis research field, grand chal-
lenges have shown to be a very successful approach to quickly
advance the state of the art. Typically, the challenge organizers
define a clinically relevant task and release a sufficiently large
and diverse training set to allow participants to build algo-
rithms to solve a specific problem. Subsequently, algorithms
are uniformly evaluated by the organizers to allow a fair
performance comparison. There have been many successful
challenges in recent years, in many medical imaging fields,
for example: liver segmentation in CT (SLIVER07) [10], brain
tumor segmentation in MRI (BRATS) [11], or lung nodule
detection in CT (LUNA16) [12].
In 2016, we organized the ’CAncer MEtastases in LYmph
nOdes challeNge’ (CAMELYON16) to improve automated
breast cancer metastases detection in whole-slide images
(WSIs) of sentinel lymph nodes [13]. As part of the chal-
lenge, we organized a reader study in which 11 pathologists
under time constraint and 1 pathologist without time-constraint
performed the same task as the algorithms in the challenge.
We found that the best performing algorithms in the challenge
perform at the level of the pathologist without time-constraint
and perform significantly better than pathologists under time
pressure. However, CAMELYON16 did not yet mimic clinical
practice, limiting the conclusions that could be drawn from its
results. We sought to amend these limitations with CAME-
LYON17. The following key changes were made to the setup
of CAMELYON16:
• In CAMELYON16 we focused on classification of single
WSIs whereas in CAMELYON17 we focus on patient-
level pN-stage prediction including multiple WSIs per
patient.
• Isolated tumor cells (ITC), the smallest type of metastasis,
were excluded in CAMELYON16 and have now been
included.
• Five centers providing cases were included instead of
only two centers, allowing for a more accurate rep-
resentation of preparation and staining diversity across
laboratories and scanners.
• The challenge data set size increased from 399 to 1399
WSIs to get a better estimate of algorithm performance
and allow participants to train better systems.
This paper discusses the results of the CAMELYON17 chal-
lenge, which were partly presented in a workshop during the
IEEE International Symposium on Biomedical Imaging (ISBI)
2017 in Melbourne, Australia. The next sections describe the
data set, the challenge setup, and the algorithm evaluation
strategy. Subsequently, we describe the methodology of the
ten best pre-workshop and two post-workshop submissions and
compare their results (ranking in Table I). Last, we discuss the
results, the limitations of the study and recommendations for
future work.
II. MATERIALS
A. Whole-slide images
We included patients from five different medical centers
from the Netherlands: slides from 130 lymph node resec-
tions from Radboud University Medical Center in Nijmegen
(RUMC), 144 from Canisius-Wilhelmina Hospital in Nij-
megen (CWZ), 129 from University Medical Center Utrecht
(UMCU), 168 from Rijnstate Hospital in Arnhem (RST),
and 140 from Laboratory of Pathology East-Netherlands in
Hengelo (LPON). Of these patients we collected glass slides
of H&E-stained sentinel lymph nodes. Whenever available,
we also collected the corresponding IHC slides, stained for
cytokeratin, to establish the reference standard. IHC slides
were generally only available for more difficult cases for which
in the H&E slides no tumor was detected on first reading.
No consecutive H&E-slides from the same lymph node were
included.
The glass slides were digitized with whole-slide scanners,
resulting in WSIs. The slides from RUMC, CWZ and RST
were scanned in the RUMC with an 3DHistech P250 whole-
slide scanner with a pixel size of 0.24 µm. The slides from
LPON were scanned locally with their Philips IntelliSite Ultra
Fast Scanner with a 0.25 µm pixel size. The UMCU used a
Hamamatsu XR C12000 whole-slide scanner with a 0.23 µm
pixel size.
The WSIs contained multiple resolution levels, with approx-
imately 1× 105 by 2× 105 pixels at the highest resolution
level. Each consecutive resolution level doubled the pixel
size in both directions and halved the pixel count in each
dimension. The typical file size of a WSI was about 4 GB,
but it varied greatly depending on the scanner and tissue
content of the image. The vendor-specific image formats were
anonymized and converted to standard multi-resolution TIFF
image files. For a description of the file format, see http:
//openslide.org/formats/generic-tiff/. The size of the complete
data set was 3030.5 GB divided as 715.9 GB and 2314.6 GB
between CAMELYON16 and CAMELYON17, respectively.
B. WSI labeling
Clinically, three types of metastases are distinguished, based
on size: macro-metastases, micro-metastases and ITC (Table
II). Although the clinical relevance of ITCs is debated, they
have to be reported by pathologists and affect the pN-stage
when no macro- or micro-metastases are present. When mul-
tiple metastases are present in a slide, the metastasis with the
largest size determines the slide label.
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TABLE I: CAMELYON17 combined leaderboard (pre- and post-workshop submissions)
Rank Team Affiliation Kappa Score
1 Lunit Lunit Inc. 0.8993
2 HMS-MGH-CCDS Harvard Medical School, Mass. General Hospital, Center for Clinical Data Science 0.8806
3 VCA-TUe Electrical Engineering Department, Eindhoven University of Technology 0.8729
4 MIL-GPAT The University of Tokyo, Tokyo Medical and Dental University 0.8567
5 Indica Labs Indica Labs 0.8554
6 chengshenghua Huazhong University of Science and Technology, Britton Chance Center for Biomedical Photonics 0.8439
7 DTU Technical University of Denmark 0.8098
8 IMT-CUHK Imsight Medical Technology, Chinese University of Hong Kong, Xiamen University 0.7718
9 desuto ContextVision 0.7640
10 METU-VISION Middle East Technical University 0.7599
11 Proscia Proscia Inc., Carnegie Mellon University, Moffitt Cancer Center 0.7594
12 ML-KA Karlsruhe Institute of Technology 0.7330
TABLE II: Rules for assigning single cells or clusters of
metastasized tumor cells to a metastasis category
Category Size
Macro-metastasis Larger than 2 mm
Micro-metastasis Larger than 0.2 mm and/or containing more
than 200 cells, but not larger than 2 mm
Isolated tumor cells Single tumor cells or a cluster of tumor cells
not larger than 0.2 mm or less than 200 cells
Every WSI was labeled with one of the ”macro”, ”micro”,
or ”ITC” metastasis categories by a pathologist, based on
the largest lesion present in the H&E stained slide using
the corresponding cytokeratin-stained slide as a reference, if
available. When no metastasis was present in the H&E stained
slide, it was labeled ”negative”. Examples are shown in Figure
1 and 2.
C. Assigning pN-stage labels
The pN-stages are based on several slides per lymph node
and, depending on the surgical procedure, several lymph
nodes per patient. Furthermore, some pN-stages are based
on lymph node locations or extra molecular tests. To keep
the total data set size of CAMELYON17 within reasonable
limits, the stages which require more than 5 lymph nodes
per patient were excluded. Furthermore, as this is an image
analysis challenge, we removed the stages that depend on non-
imaging information. The final subset of pN-stages used in the
challenge is indicated in Table III. For a full listing we refer
the reader to the seventh edition of the TNM Classification of
Malignant Tumors [3].
As it is almost impossible to find a roughly uniform dis-
tribution of patients across pN-stages at multiple institutions.
For the purpose of this challenge we decided to create artificial
patients. These artificial cases were constructed by grouping
5 WSIs from different patients from a single center as being
from one individual, where each WSI resembled one lymph
node. This facilitated a comparable pN-stage distribution be-
tween centers. We shared 40 of these artificial patients per
medical center. The training set included 20 patients from each
center with a disclosed pN-stage for each artificial patient and
the metastasis label for each individual slide in the set.
The test set was composed of another 100 artificial patients
(Table IV). The complete CAMELYON17 data set contained
1000 WSIs of H&E stained slides. The complete CAME-
LYON16 data set (training and test), was made available to
give participants a good starting point for training algorithms.
Altogether, 1399 WSIs were shared for the challenge (TableV).
TABLE III: pN-stages used in the challenge
pN-Stage Slide Labels
pN0 No micro-metastases or macro-metastases or ITC found.
pN0(i+) Only ITC found.
pN1mi Micro-metastases found, but no macro-metastases found.
pN1 Metastases found in 1 – 3 lymph nodes, of which
at least 1 is a macro-metastasis.
pN2 Metastases found in 4 - 9 lymph nodes, of which
at least 1 is a macro-metastasis.
TABLE IV: Patient-level characteristics for the CAME-
LYON17 data set
Center Total Patients Stages (Train)Train Test pN0 pN0(i+) pN1mi pN1 pN2
CWZ 20 20 4 3 5 7 1
RST 20 20 4 2 5 6 3
UMCU 20 20 8 2 4 3 3
RUMC 20 20 3 2 4 8 3
LPON 20 20 5 2 3 6 4
Total 100 100 24 11 21 30 14
TABLE V: WSI-level characteristics for the complete data set
Center Total WSIs Metastases (Train)Train Test Negative ITC Micro Macro
CWZ 100 100 64 11 10 15
RST 100 100 58 7 23 12
UMCU 250 100 165 2 34 49
RUMC 349 100 210 8 64 67
LPON 100 100 61 8 5 26
Total 899 500 558 36 136 169
D. Detailed lesion annotations
In addition to the patient and slide level labels, a pathologist
exhaustively annotated 10 WSIs from each of the 5 centers in
the CAMELYON17 training set by carefully outlining each
lesion in the WSIs with polygons (TableVI). The cytokeratin-
stained slides were used as a reference, when available.
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TABLE VI: Exhaustive annotations in the CAMELYON17
data set
Center Total WSIs Metastases (Train)ITC Micro Macro
CWZ 10 3 3 4
RST 10 2 5 3
UMCU 10 2 4 4
RUMC 10 4 3 3
LPON 10 5 2 3
Total 50 16 17 17
Additionally, the detailed annotations of the 159 WSIs with
metastases of the complete CAMELYON16 data set were
made available. The annotation polygons were shared as a
series of pixel coordinates on the highest resolution level in
XML file format.
III. METHODS
A. Challenge setup
We set up a website to share information about the challenge
and to provide an interface for all challenge-related issues. The
website was set up via https://www.grand-challenge.org, which
has hosted over 155 biomedical image analysis challenges
since 2007. The challenge website is accessible directly at
https://camelyon17.grand-challenge.org.
On the website the participants could register and find a
general overview of the challenge including the deadlines, a
brief description of the biomedical background of the problem,
a description of the data set, the rules of the challenge, the
evaluation metrics, and Python code snippets for accessing
the images and the annotations. Finally, through the website
the participants could submit their results and access a forum
to ask questions and provide comments.
Participants were granted access to the data set, fo-
rum and submission system after they registered and ac-
cepted the rules of the challenge. Anonymous participation
was not allowed. The complete data set was made avail-
able under Creative Commons Attribution-NonCommercial-
NoDerivatives 4.0 International License. The license is
available at https://creativecommons.org/licenses/by-nc-nd/4.
0/legalcode. The complete CAMELYON16 and CAME-
LYON17 data sets were shared on Google Drive. Since the
access to the services of Google are limited in the People’s
Republic of China (PRC) we mirrored the content of the shared
Google Drive to Baidu Pan which is a local service in the PRC
and can be accessed without restrictions.
The challenge aimed for a fair comparison of algorithms,
therefore participants were not allowed to use other data
sources. Making extra annotations on the training data set was
only allowed if the annotations were subsequently submitted to
the organizers along with the submission of the results so that
these annotations can be made available to other participants.
The participants had to submit their results as CSV files
through the challenge website. The deadline for pre-workshop
submissions was April 6, 2017. Maximum 3 submissions
were allowed per participant with a 4 page ISBI style paper
accompanying each submission describing their methods. The
3 submissions had to be methodologically different. Resubmis-
sions with simple hyper-parameter tuning were not allowed.
During the workshop at ISBI 2017 we presented the results
of the challenge and invited the top 5 teams to present
their methods. The results, presentations and participant’s
algorithms were shared via the challenge website after the
workshop. Subsequently, the challenge was reopened for reg-
istration and submissions.
B. Metrics and evaluation
Within the challenge, participants were scored based on the
ability of their algorithm to identify the pN-stages of the 100
test patients. To evaluate the performance of the algorithms,
we used Cohen’s kappa with 5 classes and quadratic weights
[14] which is a statistic that measures inter-observer agreement
for categorical variables.
Given n test patients and m categories (pN-stages), let nij
denote the number of patients with the ith pN-stage that were
categorized to the jth pN-stage. Let ri denote the total number
of patients with the ith pN-stage and sj the total number of
patents categorized to the jth pN-stage. Finally, let wij denote
the disagreement weight associated with the ith and the jth
pN-stages.
The weight matrix is
wij = (i− j)2, i, j ∈ 1..m (1)
The mean observed degree of disagreement is
Do =
1
n
m∑
i=1
m∑
j=1
nijwij (2)
The mean degree of disagreement expected by chance is
De =
1
n2
m∑
i=1
m∑
j=1
risjwij (3)
Weighted kappa is then defined by
κw =
De −Do
De
(4)
The κw metric ranges from −1 to +1: a negative value indi-
cates lower than chance agreement, zero indicates exact chance
agreement, and a positive value indicates better than chance
agreement. As pN-stages are ordinal, a quadratic weighted
kappa was chosen to penalize misclassification which are more
than one stage apart more severely.
In this paper we also use confusion matrices at the slide
level for the top 4 teams to assess accuracies for specific types
of metastases. This will allow us to identify the most promising
areas of improvement for the algorithms. Furthermore, we
qualitatively inspected the likelihood maps provided by the
best two contestants to assess localization performance and
identify common false positives and negatives.
Last, we assessed whether combining algorithms could lead
to even better performance than each algorithm individually.
We combined the submitted pN-stages and also the reported
slide-level labels of the best 2 up till the best 12 teams by
averaging the labels and by majority voting. The new slide-
level labels were converted to pN-stages by applying the TNM-
criteria. In case of a tie in majority voting, the highest pN-stage
or slide-level label was selected from the votes.
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Fig. 1: Example of a WSI of a H&E stained section with a delineated micro-metastasis at increasing zoom levels, and the
corresponding IHC (cytokeratin 8-18 stained) slide at the same location. The metastasis is outlined with black.
Fig. 2: Low-resolution examples of WSIs. One H&E stained slide from each medical center in the training set and the
corresponding IHC (cytokeratin 8-18 stained) slide for the last H&E stained slide.
C. Summary of submitted algorithms
We had 300 registered participants before March 1, 2017
when the test data set was released and over a 1000 by the
time of writing this article.
Altogether 23 teams submitted their results before the work-
shop deadline. To keep the paper concise we only present the
methodology and results of the ten best performing algorithms.
We also received four submissions after the challenge was re-
opened (but before 31st December 2017), of which one was a
resubmission and one was excluded for not providing sufficient
algorithmic detail. The other two post-workshop submissions
were included. This resulted in a total of twelve algorithms
which are presented in this paper.
All the twelve teams followed the same basic algorithmic
steps: preprocessing, slide-level classification, slide-level post-
processing, and patient-level classification. We first give a brief
summary and then cover each of the four steps in more detail.
In the preprocessing step all teams started with identifying
the tissue regions on the WSIs. Typically, large parts of the
slide do not contain tissue (Figure 2), and do not need to
be processed. Therefore, the preprocessing step is essential
for developing efficient algorithms. Subsequently, to perform
metastases detection in each slide, all twelve teams trained
convolutional neural networks architectures (CNN) with image
tiles extracted from the identified tissue regions (normal and
metastatic areas). The trained networks were then applied to
the test images to obtain metastasis-likelihood maps. Within
the postprocessing step, most participants thresholded the like-
lihood map and collected several features from the identified
cancerous areas and used a separate classifier (e.g. random
forest) to determine the class of the WSI: negative, ITC, micro,
or macro. Last, the participants typically followed the pN-stage
definitions to combine their slide-level findings into a patient-
level pN-stage.
1) Preprocessing: All participants used a preprocessing
step to identify tissue regions in the WSIs. All participants
used simple filtering and thresholding algorithms, mostly
Otsu’s adaptive threshold at a low resolution level [15].
Differences between the methods were mainly found in which
color space the thresholds were applied, for example RGB
(red-green-blue), HSV (hue-saturation-value), or HSI (hue-
saturation-intensity), and the type of morphological operations
that were used to refine the thresholded image. For example,
team 4 and 11 used a median filter to remove small regions,
team 5 used connected component analysis and size filtering,
and team 6 used morphological hole-filling. For a full listing
we refer to Table VII.
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TABLE VII: Differences in preprocessing and augmentation.
G: Grayscale (mean value of RGB channels), CCA: Connected
component analysis, Max/Min ∆: Threshold on the difference
between maximum and minimum value across RGB channels.
Rank Resolution Color Threshold MorphologicalLevel Space Type Operations
1 5 G Value of G -
2 5 G Otsu’s -
3 6 G Otsu’s -
4 6 HSV Otsu’s Median filter,
5 8 G Otsu’s Size filter using CCA
6 7 RGB Max/Min ∆ Hole filling
7 6 HSI, I in HSI, Remove small obj.,
H&E E in H&E Closing
8 4 G Otsu’s -
9 6 G Otsu’s -
10 2 G Value of G -
11 0 HSV Otsu’s Median filter,
Size filter using CCA
12 4 G Yen’s [16] Variance filter,
Mean filter
2) Slide-level classification: Almost all participants used
the CAMELYON16 WSIs, the 50 exhaustively annotated
CAMELYON17 WSIs, and all the negative WSIs from the
CAMELYON17 data set to develop their algorithms. Team 4,
7 and 12 used only the CAMELYON16 data set.
With respect to the different types of algorithms, all partici-
pants used CNNs. Specifically, they used variants of common
network architectures: ResNet [17], GoogLeNet/Inception
[18], VGG-Net [19], U-Net [20], and one team used DenseNet
[21]. In contrast to CAMELYON16, none of the included
twelve algorithms used a custom architecture. Team 2 and 4
used significantly adapted versions of the common architec-
tures. Team 2 used a variant of ResNet-101 called DeepLab
[22]. DeepLab employs convolution with dilated filters instead
of downsampling (e.g. max-pooling) to increase the spatial
resolution of the network when applied in a fully-convolutional
fashion. Furthermore, in order to combat reduced localization
accuracy due to inherent translational invariance in CNNs
the architecture also uses conditional random fields (CRF).
Team 4 used GoogLeNet in their ensemble to create texture
representation by taking the location-wise outer product of
the feature maps at the ’inc4d’ layer. Subsequently, these are
averaged across location to obtain a single feature vector. This
vector is then fed into a softmax classifier. This approach is
similar to that of the bilinear CNNs [23].
Five of the teams used model ensembles but only 2 teams,
team 4 and 12 used fundamentally different networks in their
ensembles. For example, team 4 used a combination of 2
GoogLeNets with different input patch sizes and a Resnet-50
architecture. The rest of the teams used instances of the same
architecture with different initialization, parameters or patch
augmentation settings. Eight of the teams used pre-trained
networks for the challenge. They all used networks that were
pre-trained on the ImageNet challenge [24], except team 2
who used a network that has been pre-trained on Microsoft
COCO challenge [25].
All participants extracted small image patches of metastases
and normal areas from the WSIs to train their CNNs, although
the exact patch size and pixel resolution differed substantially.
For the complete details of the network architectures and
training parameters we refer to Table VIII.
In addition, almost all teams performed extensive data
augmentation to increase the variation in the training set;
only team 6 did not use any data augmentation. Random
mirroring and rotations of 90°, 180°and 270°were the most
popular augmentation strategies. Two teams applied rotations
with angles sampled from the continuous [0°, 360°] interval
instead. Other strategies included random cropping of patches,
and applying affine transformations (e.g. scaling).
In addition, to make their CNNs robust to color varia-
tion caused by differences between scanners and/or staining
protocols, most participants used patch color augmentation
in the HSV, RGB or H&E color spaces by adding noise
to the individual color channels. Some of the teams used
additional brightness, contrast and gamma adjustments. Two
teams took a completely different approach and tried to use
stain normalization algorithms [26] to ensure a uniform color
distribution across the images. For the complete details of the
augmentation strategies we refer to Table IX.
3) Slide-level postprocessing: All participants used the
trained networks to generate metastasis-likelihood maps for
the WSIs. Team 3 used test time augmentations to generate the
likelihood map. Test time augmentation refers to the practice
of applying training augmentations to patches at test time to
get multiple metastasis likelihoods per patch. Often these are
then averaged to obtain the final likelihood for that patch, but
team 3 used the most certain likelihood (i.e. closest to 1.0). To
obtain the actual metastasis candidates most teams thresholded
the likelihood maps and post-processed the resultant binary
masks. A typical strategy, used for example by team 1 and 6
is to remove small detections to reduce the amount of false
positives. Instead of thresholding, team 3 and team 12 used
conditional random fields to assign pixel labels [27].
Assigning a slide-level label is trivial in case of perfect
pixel level classification: a metastasis class can be assigned
by measuring the largest detected area (Table II). Only two
teams used this approach in CAMELYON17. As we already
learned in the CAMELYON16 challenge, many algorithms
submitted by participants suffer from high false positive rates
[13]. The winner in CAMELYON16 solved this by extracting
features from the binary detection mask and the likelihood map
and feeding these features to a random forest classifier. This
approach was replicated by several participants in CAME-
LYON17. Features that were typically used are, for example,
the number of detected metastases, mean detection size and
standard deviation, mean detection likelihood and standard
deviation. Team 3 used a different approach by applying a
more extensive rule-based system. To better separate between
micro-metastases and ITC, they tried to calculate the number
of cells via color deconvolution and thresholding on the
hematoxylin channel. Subsequently, the DBSCAN algorithm
was used to group together small metastases areas which were
in close proximity [28].
Most teams determined the patient-level pN-stages by ap-
plying the rules according to the definition of pN-stages,
except team 9 and 12. Team 9 combined the extracted features
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TABLE VIII: Network architecture and training details. DO: Dropout, HNM: Hard Negative Mining
Rank Architecture Pre-trained Ensemble Batch Patch Image Batch Iterations Training L2 DO HNM(Size) Norm Sizes Level Size Set Size Loss
1 ResNet-101 ImageNet x (3) x 256 × 256 0 32 5× 105 4.5× 107 - - -
2 ResNet-101 COCO - x 960 × 960 1 10 2× 104 1.6× 106 x - x
3 GoogLeNet ImageNet - x 299 × 299 1 32 9.5× 104 3× 106 x x x
4 GoogLeNet, ImageNet x (3) - 256 × 256, 0 128 1× 105 5× 105 x - x
ResNet-50 512 × 512
5 VGG ImageNet - - 435 × 435 0 1 1.3× 106 1.3× 106 x x -
6 GoogLeNet ImageNet - x 299 × 299 0 32 1× 105 1.2× 107 - x x
7 GoogLeNet - - x 128 × 128 1 32 3.2× 104 1× 106 - x x
8 VGG ImageNet - - 244 × 244 0 75 3× 105 1.3× 107 x x x
9 U-Net - - - 512 × 512 2 20 1.5× 106 1.3× 106 - - x
10 U-Net - x (2) - 256 × 256, 2 16 5.3× 105 1.1× 106 - - -
512 × 512
11 GoogLeNet ImageNet - - 256 × 256 0 32 2.5× 105 5× 106 x - -
12 Dense U-Net, - x (3) x 416 × 416 2 4 - 75 2.5× 105 1.8× 105 x x -
Densenet
TABLE IX: Augmentation methods. AT: Affine transforma-
tions, AGN: Additive Gaussian noise, M90: multiples of 90°
Rank Mirroring Rotation Color Other
1 x [0°, 360°] HSV contrast
2 x - RGB brightness and
contrast
3 x M90 HSV -
4 x M90 - cropping
5 x M90 HSV -
6 - - - -
7 x M90 H&E gamma adjustment
8 x [0°, 360°] RGB cropping
9 x M90 stain norm. -
10 x M90 - -
11 x M90 stain norm. brightness, zoom,
AT, and AGN
12 x M90 HSV contrast
of all 5 slides per patient and used gradient boosted trees to
determine the pN-stage of the patient directly. Team 12 on the
other hand used a regression on slide-level prediction instead
of direct rule based method to construct pN-stage from slide
classifications.
Team 10 built a two stage binary decision tree to determine
the metastases category on the individual slides. First they
differentiated between negative and ITC; or micro and macro
categories. Then they further divided the two sets into negative
or ITC; and micro- or macro-metastases accordingly. At each
step they used a different combination of the outputs of
the 2 networks. For the complete details of the slide-level
postprocessing we refer to Table X.
IV. RESULTS
The metric used to rank the algorithms, the quadratic-
weighted κ score, ranged from 0.8993 to -0.1341 for all 23
participating teams and from 0.8993 to 0.7330 for the methods
included in this paper. As such, in terms of agreement,
performance ranged from near-perfect agreement to worse-
than-chance when including all participants. For a complete
listing of the top 12 teams and their κ scores we refer to
Table I.
TABLE X: Likelihood map postprocessing, slide-level classifi-
cation and pN-stage assignment. TH: Threshold, CRF: Condi-
tional Random Field, RFC: Random Forest Classifier, RBS:
Rule-based System, GBT: Gradient Boosted Trees, SVM:
Support Vector Machine.
Rank Likelihood Map Binary Mask Slide-level pN-StageFiltering Generation Classifier Assignment
1 - 1 TH RFC rule-based
2 - 2 THs RFC rule-based
3 upsampling CRF RBS rule-based
4 - 3 THs RFC rule-based
5 - 3 THs - rule-based
6 - 1 TH RFC -
7 - 1 TH RFC rule-based
8 - 5 THs RFC rule-based
9 - - GBT model-based
10 downsampling 1 TH - rule-based
11 Gaussian Otsu’s RFC rule-based
filtering
12 morphological CRF SVM regression
smoothing
Confusion matrices at the slide-level were also generated
for the best 4 teams to inspect the quantitative results in more
detail (Table XI). We can see that all teams performed well
in identifying negative slides and slides containing macro-
metastases. All teams performed poorly in identifying ITC,
although the range in accuracy is quite large (0 – 34.3%
correct). Teams 1 and 2 additionally performed well on slides
containing micro-metastases, whereas team 3 and 4 performed
significantly worse.
When combining the submissions of multiple teams a best
κ score of 0.9261 was obtained by combining the slide-level
classification of teams 1, 2 and 3 by averaging slide-level
labels. This is 0.0268 higher than the single best team. The
κ scores of the 5 best combinations are shown in Table XII.
Focusing on the pN-stage classification specifically, the best
single team assigned 76 out of 100 patients to the correct pN-
stage, whereas the best combination got 77 out of 100 correct.
Furthermore, the largest difference between the predicted pN-
stage and the reference pN-stage was 3 stages for team 1 and
only 2 stages for the best combination. Miss with larger than
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TABLE XI: Slide-level confusion matrices of the best four teams with the accuracy indicated in percentages. BC is the best
combination of algorithms. The cell colors range from white, representing low error rate to red, representing high error rate.
1 difference occurred 5 times for the single best algorithm
and only twice for the best combination. At slide-level the
best combination performed equally on negative and macro-
metastasis class slides, a few percentage points worse on
micro-metastasis class slides but was almost 30 percentage
points better in identifying ITC (Table XI).
TABLE XII: Kappa scores of different algorithm combination
outputs
Teams Type Combination Kappa Score
1 – 3 slide-level mean 0.9261
1 – 3 slide-level majority 0.9236
1 – 5 slide-level majority 0.9226
1 – 3 patient-level mean 0.9209
1 – 2 patient-level mean 0.9175
Evaluation of the likelihood maps of team 1 and 2 provided
insight in the performance of their algorithms, and clarified
some of the false positives and false negatives. Examples
of the likelihood maps are depicted in Figure 3. On the
first row, a nerve is depicted that was identified by both
teams as a metastasis. On the second row of Figure 3 an
example of contamination is shown. The tissue sample was
contaminated with a small piece of breast tissue during glass
slide preparation. This contamination is not a metastasis but
was picked up as such by both systems. Rows three and
four show a macro- and micro-metastasis, respectively. The
macro-metastasis was missed by team 1 and misclassified
as a micro-metastasis by team 2. The micro-metastasis was
missed by both teams. Both these metastases showed very
diffuse infiltration of the healthy tissue, making it challenging
to identify them. Last, the fifth row shows a micro-metastasis
nicely segmented by both team 1 and 2. The detection of team
1 was a bit more precise since they correctly identified the
extending arms on the top left and right side.
V. DISCUSSION
Given that the participation requirements for CAME-
LYON17 were very high in terms of amounts of data that had
to be processed within a limited time frame, both the quality
and quantity of submissions was high. With 37 submissions, it
was even slightly higher than for CAMELYON16, which had
32 submissions at the initial deadline.
The submitted algorithms were not only able to detect
the presence of metastases but also measure their extent to
derive the metastasis category, including ITC, and to determine
the pN-stage that is used in clinical practice. Therefore, the
outcome of CAMELYON17 more directly relates to clinical
practice and the submitted algorithms can more readily be
evaluated in that context.
A key observation is that the best performing algorithms do
well on slides containing macro-metastases and metastasis-free
slides. However, even the current best algorithm still performs
very poorly on identifying ITC with only 11.4% accuracy. It
has to be noted that ITC only play a very limited role in the
pN-staging system and often are also missed by pathologists
on H&E-stained slides [8]. These very small metastases can
subsequently be picked up by using additional IHC staining.
The data set contained only 36 whole-slide images with
ITCs of which only 16 were annotated. This could limit the
performance of the algorithms detecting ITC. However, we
think another reason might be also be important: to achieve
high sensitivity on the small ITC lesions, one most likely needs
to allow more small false positives in normal cases (i.e. it is
harder to get rid of spurious detections automatically). For
example, team 3, which used a rule-based system to obtain
slide level classifications, was the best in ITC detection but at
a cost of the highest false positive ratio in normal images.
The most important aspect of a well-performing system in
terms of pN-staging and clinical relevance is its ability to
detect macro- and micro-metastases. There are only relatively
minor differences in the ability of the best systems to pick-up
macro-metastases as the accuracies are within 5%. As such,
most of the difference in the ranking is caused by the ability
of the top two to identify micro-metastases much better than
all other algorithms.
With regard to false positive detections, all algorithms still
struggle with benign areas that occur rarely in the training set,
for example the nerve shown in Figure 3 or contamination
caused by tissue processing in the lab. Several teams tried to
circumvent this by including hard-negative mining steps, but
with limited success. Most likely this is caused by the fact
that these benign areas are so rare that it is impossible to
learn an accurate representation, even with the three terabytes
of data in the CAMELYON17 data set. A potential avenue
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to address this issue is by incorporating model uncertainty,
for example via test-time dropout [29]. Another type of false
positive which is hard to address is the contamination shown
in row 2 of Figure 3. This can only be identified as a false
positive detection when the global context of the slide is taken
into consideration. As all competing algorithms use mostly
local information (i.e. patches) to train their models, this can
not be incorporated. An efficient strategy to add this global
context to deep networks is interesting for further research.
We tried to identify the key characteristics in terms of
methodology for the top performing algorithms. One important
observation is that it is not possible to achieve competitive
results using only a pre-trained GoogLeNet. Many groups tried
this approach, modeled after the winner of CAMELYON16,
but their results vary substantially. We also know from CAME-
LYON16 that pre-training in itself does not improve perfor-
mance, but does offer the benefit of much faster convergence
[30]. Especially in the context of a time-limited challenge,
the reduced training time is beneficial. The fact that results
vary substantially, even when using the same, pre-trained
architecture indicates that the way the networks are trained
or fine-tuned is more important than the architecture itself.
Observing the training processes used by the teams that are
included in this paper, it can be concluded that the data being
fed to the system is inherently important. All the participating
teams extracted high-resolution patches from the WSIs. The
best eight algorithms used either level 0 (0.25 µm pixel size)
or level 1 (0.5 µm pixel size). The details that are available on
high resolution levels are likely necessary for achieving good
performance for this task. The amount of context included
in the patches did vary greatly between teams. The smallest
spatial area was 256 × 256 pixels at the highest resolution
level, while the the largest spatial area corresponds to 1920 ×
1920 pixels at that same level. Given the results, the context
provided by 256 × 256 pixels at level 0 was enough for
achieving good performance; larger contexts were not needed.
An interesting characteristic of the best performing algo-
rithm is that it was trained for up to a magnitude more
iterations than most of the other contenders. Only team 5,
9 and team 10 trained longer but they were either using a
VGG architecture, which has roughly three times as many
parameters as the ResNet-101 used by team 1, or U-net,
which has not been pre-trained. Team 1 also used the largest
number of patches in their training set of all contenders. These
observations together might indicate that this network has
learned from a more varied set of patches, which could explain
why it generalizes best on the test set.
The majority of the teams focused on the most challenging
patches using hard negative mining. This seemed to benefit
performance overall as it was used by seven out of ten best
teams, even though the best performing team did not use it.
In CAMELYON17, the hard negative mining was used more
widely than in CAMELYON16, where only two of the top-
performing algorithms used it.
One of the other lessons learned from CAMELYON16 was
that proper handling of stain variation between centers is key
to good performance. In CAMELYON17 this is even more
important as we now included 5 centers instead of 2. In
CAMELYON16 the best performing team used color normal-
ization to pre-process all the slides, whereas in this challenge
most of the teams relied on heavy color augmentation to
force their networks to be robust to color variation. In clinical
practice such networks would be more desirable since they do
not rely on a preprocessing step that could potentially fail.
A common question after every Grand Challenge in medical
image analysis is whether the problem, in this case automatic
identification of breast cancer metastases in sentinel lymph
nodes, has been adequately solved. Up till now we can
confidently state that this is not yet the case. Despite the
excellent results of the participating teams the fact that a
straightforward combination of the 3 top teams yields a 0.0268
better kappa score than the current best of 0.8993 shows
that there is still room for improvement for the individual
algorithms. Even more so when we take into account that even
the best combination only classifies 77 out of 100 patients
correctly. The errors are even worse at the slide level. The
best ranked team misclassified 67 of the 500 slides in the test
set. Overall 10 slides containing micro-metastases and 4 slides
containing macro-metastases were classified as negative. That
would be an unacceptable error in clinical practice. Although
the poor performance on ITC is not immediately relevant from
a clinical perspective, it could undermine the trust clinicians
have in such algorithms. Improving the algorithm performance
in this aspect is thus still worthwhile.
In terms of future work, the CAMELYON17 challenge
will remain open for new submissions to allow improved
algorithms to obtain better results. With respect to extending
the scope of the challenge, adding the IHC stains as an
extra layer of information is an option which would bring
the challenge even closer to clinical practice. Alternatively,
lymph nodes with metastases from other tumor entities, such
as melanoma or colon cancer could be added. From a practical
perspective, sharing 3 terabytes of data with participants all
around the world has been challenging. Increasing the data size
even further could render an expanded challenge impractical
or impossible for many to participate in. A possible alternative
would be to host the data at a single location and provide an
environment to the participants that they could access remotely
and where they could use the data to develop their algorithms
without having to download it.
Summarizing, the algorithms competing in CAMELYON17
have proven that it is possible to automatically analyze
histopathological WSIs in a clinically relevant setting, but can
not yet be implemented without some form of supervision
by a clinical expert. In their current state the algorithms
could potentially effectively aid clinicians by pre-screening
the WSIs. The pre-screened images could steer the attention
of the pathologist to the relevant areas and ease the pN-staging
by outlining metastases in advance.
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Fig. 3: Examples of likelihood maps. Columns: maps of teams 1 and 2 on low and high magnifications. Rows: nerve,
contamination, missed macro-metastasis, missed micro-metastasis, identified micro-metastasis. The colors range from green
to red, representing low to high probability respectively. The reference is annotated in black.
